Benzinga's Top Ratings Upgrades, Downgrades For August 20, 2021

 

Upgrades

  • For Investors Bancorp Inc ISBC, Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. In the second quarter, Investors Bancorp showed an EPS of $0.34, compared to $0.18 from the year-ago quarter. The stock has a 52-week-high of $15.71 and a 52-week-low of $6.74. At the end of the last trading period, Investors Bancorp closed at $13.44.
  • Loop Capital upgraded the previous rating for Leslies Inc LESL from Hold to Buy. Leslies earned $0.64 in the third quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $32.84 and a 52-week-low of $19.15. At the end of the last trading period, Leslies closed at $21.60.
  • According to JP Morgan, the prior rating for Macy's Inc M was changed from Underweight to Neutral. In the second quarter, Macy's showed an EPS of $1.29, compared to $0.81 from the year-ago quarter. The current stock performance of Macy's shows a 52-week-high of $22.30 and a 52-week-low of $5.57. Moreover, at the end of the last trading period, the closing price was at $21.61.
  • According to HSBC, the prior rating for CF Industries Holdings Inc CF was changed from Hold to Buy. CF Industries Holdings earned $1.14 in the second quarter, compared to $0.89 in the year-ago quarter. The stock has a 52-week-high of $57.19 and a 52-week-low of $25.30. At the end of the last trading period, CF Industries Holdings closed at $43.34.
  • For The Mosaic Co MOS, HSBC upgraded the previous rating of Hold to Buy. Mosaic earned $1.17 in the second quarter, compared to $0.11 in the year-ago quarter. The current stock performance of Mosaic shows a 52-week-high of $38.23 and a 52-week-low of $16.01. Moreover, at the end of the last trading period, the closing price was at $29.57.
  • For FibroGen Inc FGEN, Raymond James upgraded the previous rating of Underperform to Market Perform. FibroGen earned $1.45 in the second quarter, compared to $0.95 in the year-ago quarter. The stock has a 52-week-high of $57.21 and a 52-week-low of $11.47. At the end of the last trading period, FibroGen closed at $11.47.

See all analyst ratings upgrades.

 

Downgrades

  • For Phillips 66 PSX, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. Phillips 66 earned $0.74 in the second quarter, compared to $0.74 in the year-ago quarter. At the moment, the stock has a 52-week-high of $94.34 and a 52-week-low of $43.27. Phillips 66 closed at $66.27 at the end of the last trading period.
  • Argus Research downgraded the previous rating for Leidos Holdings Inc LDOS from Buy to Hold. For the second quarter, Leidos Holdings had an EPS of $1.52, compared to year-ago quarter EPS of $1.55. The current stock performance of Leidos Holdings shows a 52-week-high of $113.75 and a 52-week-low of $79.15. Moreover, at the end of the last trading period, the closing price was at $96.67.
  • BTIG downgraded the previous rating for Performance Food Group Co PFGC from Buy to Neutral. In the fourth quarter, Performance Food Group showed an EPS of $0.56, compared to $0.86 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.89 and a 52-week-low of $31.69. Performance Food Group closed at $42.92 at the end of the last trading period.
  • RBC Capital downgraded the previous rating for Duke Energy Corp DUK from Outperform to Sector Perform. In the second quarter, Duke Energy showed an EPS of $1.15, compared to $1.08 from the year-ago quarter. The current stock performance of Duke Energy shows a 52-week-high of $108.38 and a 52-week-low of $78.95. Moreover, at the end of the last trading period, the closing price was at $106.88.
  • According to Raymond James, the prior rating for Healthcare Trust of America Inc HTA was changed from Outperform to Market Perform. In the second quarter, Healthcare Trust showed an EPS of $0.44, compared to $0.42 from the year-ago quarter. The stock has a 52-week-high of $29.72 and a 52-week-low of $23.39. At the end of the last trading period, Healthcare Trust closed at $29.66.
  • Raymond James downgraded the previous rating for Healthcare Realty Trust Inc HR from Strong Buy to Market Perform. For the second quarter, Healthcare Realty Trust had an EPS of $0.43, compared to year-ago quarter EPS of $0.42. The stock has a 52-week-high of $34.01 and a 52-week-low of $26.77. At the end of the last trading period, Healthcare Realty Trust closed at $29.89.
  • For Pinnacle West Capital Corp PNW, Goldman Sachs downgraded the previous rating of Neutral to Sell. Pinnacle West Capital earned $1.91 in the second quarter, compared to $1.71 in the year-ago quarter. At the moment, the stock has a 52-week-high of $91.88 and a 52-week-low of $69.29. Pinnacle West Capital closed at $80.08 at the end of the last trading period.
  • For Inovalon Holdings Inc INOV, BTIG downgraded the previous rating of Buy to Neutral. In the second quarter, Inovalon Holdings showed an EPS of $0.19, compared to $0.15 from the year-ago quarter. At the moment, the stock has a 52-week-high of $40.50 and a 52-week-low of $17.56. Inovalon Holdings closed at $40.32 at the end of the last trading period.
  • Cowen & Co. downgraded the previous rating for Ontrak Inc OTRK from Market Perform to Underperform. For the second quarter, Ontrak had an EPS of $0.12, compared to year-ago quarter EPS of $0.37. The stock has a 52-week-high of $99.89 and a 52-week-low of $11.51. At the end of the last trading period, Ontrak closed at $11.68.
  • For Aprea Therapeutics Inc APRE, JP Morgan downgraded the previous rating of Neutral to Underweight. In the second quarter, Aprea Therapeutics showed an EPS of $0.48, compared to $0.78 from the year-ago quarter. The current stock performance of Aprea Therapeutics shows a 52-week-high of $31.45 and a 52-week-low of $3.38. Moreover, at the end of the last trading period, the closing price was at $3.43.
  • Goldman Sachs downgraded the previous rating for Intercept Pharmaceuticals Inc ICPT from Neutral to Sell. For the second quarter, Intercept Pharmaceuticals had an EPS of $0.33, compared to year-ago quarter EPS of $1.92. The current stock performance of Intercept Pharmaceuticals shows a 52-week-high of $50.75 and a 52-week-low of $13.29. Moreover, at the end of the last trading period, the closing price was at $13.84.

See all analyst ratings downgrades.

 

Initiations

  • Oppenheimer initiated coverage on AngioDynamics Inc ANGO with a Perform rating. In the fourth quarter, AngioDynamics showed an EPS of $0.00, compared to $0.06 from the year-ago quarter. The current stock performance of AngioDynamics shows a 52-week-high of $30.25 and a 52-week-low of $8.95. Moreover, at the end of the last trading period, the closing price was at $27.36.
  • Benchmark initiated coverage on Alterity Therapeutics Ltd ATHE with a Speculative Buy rating. The price target for Alterity Therapeutics is set to $4.00. The stock has a 52-week-high of $3.58 and a 52-week-low of $1.09. At the end of the last trading period, Alterity Therapeutics closed at $1.28.
  • With a Strong Buy rating, Raymond James initiated coverage on Byrna Technologies Inc BYRN. The price target seems to have been set at $36.00 for Byrna Technologies. In the second quarter, Byrna Technologies earned $0.16. At the moment, the stock has a 52-week-high of $27.27 and a 52-week-low of $1.33. Byrna Technologies closed at $24.30 at the end of the last trading period.
  • Piper Sandler initiated coverage on OppFi Inc OPFI with a Neutral rating. The price target for OppFi is set to $7.00. OppFi closed at $6.21 at the end of the last trading period.
  • William Blair initiated coverage on Ryan Specialty Group Holdings Inc RYAN with an Outperform rating.  Ryan Specialty Group closed at $30.25 at the end of the last trading period.
  • For WSFS Financial Corp WSFS, Seaport Global initiated coverage, by setting the current rating at Neutral. WSFS Financial earned $2.00 in the second quarter, compared to $0.46 in the year-ago quarter. At the moment, the stock has a 52-week-high of $55.18 and a 52-week-low of $24.59. WSFS Financial closed at $44.24 at the end of the last trading period.
  • HC Wainwright & Co. initiated coverage on NextPlay Technologies Inc NXTP with a Buy rating. The price target for NextPlay Technologies is set to $3.00. Interestingly, in the fourth quarter, NextPlay Technologies's EPS was $0.61. The stock has a 52-week-high of $2.39 and a 52-week-low of $1.62. At the end of the last trading period, NextPlay Technologies closed at $1.81.
  • With a Buy rating, Goldman Sachs initiated coverage on Perella Weinberg Partners PWP. The price target seems to have been set at $16.50 for Perella Weinberg Partners. Interestingly, in the second quarter, Perella Weinberg Partners's EPS was $0.32. The stock has a 52-week-high of $14.60 and a 52-week-low of $11.84. At the end of the last trading period, Perella Weinberg Partners closed at $13.29.
  • Keybanc initiated coverage on Janus International Group Inc JBI with an Overweight rating. The price target for Janus Intl Gr is set to $18.00. In the second quarter, Janus Intl Gr showed an EPS of $0.02, compared to $0.17 from the year-ago quarter. The current stock performance of Janus Intl Gr shows a 52-week-high of $15.50 and a 52-week-low of $12.06. Moreover, at the end of the last trading period, the closing price was at $14.45.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!